THE C-REACTIVE PROTEIN ACCORDING TO LUNG INVOLVEMENT OF COVID-19 PATIENTS AT VERY HIGH ALTITUDE

Proteína C reactiva en COVID-19 en alta altitud

Authors

  • Alejandra Regina Maceda Maidana Boliviana

DOI:

https://doi.org/10.52428/20756208.v9i21.1111

Keywords:

COVID-19, C-reactive protein, CO-RADS reporting system, prognosis

Abstract

Introduction

The protein C-reactive is an important immunological marker due to its sensitivity to stimulate inflammation and or infections, it is necessary to study its role in the lung compromise and the evolution of COVID-19 disease. The objective of the present study is to determine the behavior of C-Reactive Protein according to lung involvement, in patients with a positive diagnostic of COVID-19 in the Hospital del Norte in El Alto, from 2021.

Material and method

It is a study which is characterize of observations, explanations, transversal, retrospective, due to a random simple sampling of 196 patients with a diagnosis of pneumonia and a positive RT-PCR test. There was a statistical analysis performed by the test of “chi cuadrado” where the variable depends on a report CORADS (compromise lung) and the independent variable is the protein C-reactive. Therefore, it can be calculate the frequency of variables: sex, age, type of relation between the age, PCR and CORADS and relation between the discharge types.

Results

196 subjects with the diagnostic of pneumonia and a positive RT-PCR were studied. There were found statistically a significance concentration between C-reactive protein and lung compromise (p = 0.000 < 0.05).

Discussion

The present study showed that there is a positive association between C - reactive protein concentrations and lung involvement. In view of the p-value obtained (p=0.01 < α=0.05), the existence of a statistical dependence between pulmonary involvement and the concentrations of C-Reactive protein is evident, the pulmonary involvement reported by the CORAD system varies in relation to the concentration of C-Reactive Protein

Keywords: COVID-19, CRP, CORADS.

Downloads

Download data is not yet available.

References

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA [Internet]. 7 de abril de 2020 [citado 20 de septiembre de 2023];323(13):1239-42. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32091533/

https://doi.org/10.1001/jama.2020.2648

PMid:32091533

Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 2020 176 [Internet]. 19 de marzo de 2020 [citado 22 de septiembre de 2023];17(6):613-20. Disponible en: https://www.nature.com/articles/s41423-020-0400-4

https://doi.org/10.1038/s41423-020-0400-4

PMid:32203189 PMCid:PMC7091888

Cecconi M, Forni G, Mantovani A. Ten things we learned about COVID-19. Intensive Care Med. 2020 Aug;46(8):1590-1593. doi: 10.1007/s00134-020-06140-0

https://doi.org/10.1007/s00134-020-06140-0

PMid:32504103 PMCid:PMC7273118

Del Rio, C., & Malani, P. N. (2020). COVID-19-New Insights on a Rapidly Changing Epidemic. JAMA, 323(14), 1339-1340. https://doi.org/10.1001/jama.2020.3072

https://doi.org/10.1001/jama.2020.3072

PMid:32108857

Penha D, Pinto EG, Matos F, Hochhegger B, Monaghan C, Taborda-Barata L, et al. CO-RADS: Coronavirus Classification Review. J Clin Imaging Sci [Internet]. 2021 [citado 22 de septiembre de 2023];11(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/33767901/

https://doi.org/10.25259/JCIS_192_2020

PMid:33767901 PMCid:PMC7981938

Wanderley F. Serie Reflexiones sobre la Pandemia en Bolivia No 3 LOS IMPACTOS SOCIALES Y PSICOLÓGICOS DEL COVID-19 EN BOLIVIA. [citado 20 de septiembre de 2023]; Disponible en: http://www.iisec.ucb.edu.bo/video-categoria/seminarios-y-conferencias

Ministerio de Salud y Deportes de Bolivia - GOBIERNO DECLARA EMERGENCIA SANITARIA A NIVEL NACIONAL ANTE INCREMENTO DE CASOS COVID-19 EN EL PAÍS [Internet]. [citado 25 de marzo de 2024]. Disponible en: https://www.minsalud.gob.bo/6360-gobierno-declara-emergencia-sanitaria-a-nivel-nacional-ante-incremento-de-casos-covid-19-en-el-pais

EL ALTO Estudio con información estadística, descriptiva y analítica sobre las condiciones, oportunidades e institucionalidad de la población y la ciudad. Disponible en : https://searchworks.stanford.edu/view/9426323

Vaquero-Roncero LM, Sánchez-Barrado E, Escobar-Macias D, Arribas-Pérez P, González de Castro R, González-Porras JR, Sánchez-Hernandez MV; COVID Working Group. C-Reactive protein and SOFA scale: A simple score as early predictor of critical care requirement in patients with COVID-19 pneumonia in Spain. Rev Esp Anestesiol Reanim (Engl Ed). 2021 Nov;68(9):513-522. doi: 10.1016/j.redare.2020.11.008.

https://doi.org/10.1016/j.redare.2020.11.008

PMid:34743905 PMCid:PMC8568297

Fink MP. The prevention and treatment of sepsis: Is interleukin-6 a drug target or a drug? Crit Care Med [Internet]. marzo de 2006 [citado 21 de marzo de 2024];34(3):919-21. Disponible en: https://journals.lww.com/ccmjournal/fulltext/2006/03000/the_prevention_and_treatment_of_sepsis__is.62.aspx

https://doi.org/10.1097/01.CCM.0000203108.60429.DF

PMid:16505686

Fauci A, Langford C. Harrison's Rheumatology. 2010 [citado 21 de marzo de 2024];361. Disponible en: https://books.google.com/books/about/Harrison_s_Rheumatology_Second_Edition.html?hl=es&id=kKtbeHwxDb8C

Abbas AK, Lichtman AH, Pillai S. Chapter 8: Lymphocyte Development and Antigen Receptor Gene Rearrangement . Preview Cell Mol Immunol [Internet]. 2021 [citado 21 de marzo de 2024];187-216. Disponible en: https://www.elsevier.com/books/cellular-and-molecular-immunology/abbas/978-0-323-75748-5

Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, et al. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol [Internet]. 1995 [citado 21 de marzo de 2024];102(1):217-23. Disponible en: https://pubmed.ncbi.nlm.nih.gov/7554393/

https://doi.org/10.1111/j.1365-2249.1995.tb06659.x

PMid:7554393 PMCid:PMC1553348

Scheller J, Grötzinger J, Rose-John S. Updating interleukin-6 classic- and trans-signaling. Signal Transduct [Internet]. 1 de agosto de 2006 [citado 21 de marzo de 2024];6(4):240-59. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/sita.200600086

https://doi.org/10.1002/sita.200600086

Hurlimann J, Thorbecke GJ, Hochwald GM. The liver as the site of C-reactive protein formation. J Exp Med [Internet]. 1966 [citado 20 de septiembre de 2023];123(2):365-78. Disponible en: https://pubmed.ncbi.nlm.nih.gov/4379352/

https://doi.org/10.1084/jem.123.2.365

PMid:4379352 PMCid:PMC2138142

Gryska K, Stupianek A, Laciak M, Gorny A, Mackiewicz K, Baumann H, et al. Inflammatory cytokines controlling branching of N-heteroglycans of acute phase protein. Adv Exp Med Biol. 1995;376:239-45.

https://doi.org/10.1007/978-1-4615-1885-3_26

PMid:8597254

Gershow D, Kim S BN et al. C-reactive protein binds to apoptotic cells, protects the cell from assembly to the terminal complement components, and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity. 2000 [citado 20 de septiembre de 2023]. p. 1353-63 C-reactive protein binds to apoptotic cells, protects the cell from assembly to the terminal complement components, and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity. J Exp Med. Disponible en: https://rupress.org/jem/article-pdf/192/9/1353/1701865/000697.pdf

https://doi.org/10.1084/jem.192.9.1353

PMid:11067883 PMCid:PMC2193350

Pepys, M. B., & Hirschfield, G. M. (2003). C-reactive protein: a critical update. The Journal of clinical investigation, 111(12), 1805-1812. https://doi.org/10.1172/JCI18921

https://doi.org/10.1172/JCI18921

PMid:12813013 PMCid:PMC161431

Verma, S., Li, S. H., Badiwala, M. V., Weisel, R. D., Fedak, P. W., Li, R. K., Dhillon, B., & Mickle, D. A. (2002). Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 105(16), 1890-1896. https://doi.org/10.1161/01.cir.0000015126.83143.b4

https://doi.org/10.1161/01.CIR.0000015126.83143.B4

PMid:11997273

Baez AM, Ríos-González CM. Thrombotic arterial complications in patients hospitalized for COVID-19 in a regional hospital in Paraguay. Rev del Nac. 1 de junio de 2023;15(1):47-58. Disponioble en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2072-81742023000100047

https://doi.org/10.18004/rdn2023.jun.01.047.058

González Del Castillo, J., Jacob, J., García-Lamberechts, E. J., Piñera Salmerón, P., Alquézar-Arbé, A., Llorens, P., Jiménez, S., Quero Espinosa, F. B., Aguiló, S., Gil-Rodrigo, A., Fernández Alonso, C., Burillo-Putze, G., Espinosa Fernández, B., Suero Méndez, C., Iglesias Vela, M., Quero Motto, E., Hong Cho, J. U., Llopis, F., Marrón, R., Gayoso Martín, S., Red de investigación SIESTA (2022). Sociodemographic characteristics, comorbidity, and baseline functional status of older patients treated in emergency departments during the COVID-19 pandemic and associations with mortality: an analysis based on the EDENCOVID cohort. Sociodemografía, comorbilidad y situación funcional basal de los pacientes mayores atendidos en urgencias durante la pandemia de COVID y su relación con la mortalidad: análisis a partir de la cohorte EDEN-Covid. Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, 34(6), 428-436. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36625692/

Pusineri Escobar P, González-Gómez M, Barrios I, Torales J, Pusineri Escobar P, González-Gómez M, et al. Mortalidad en adultos con COVID-19: experiencia de la Unidad de Cuidados Intensivos de un Hospital de Tercer Nivel de Paraguay. Med clínica y Soc [Internet]. 1 de enero de 2023 [citado 14 de marzo de 2024];7(1):5-10. Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2521-22812023000100005&lng=en&nrm=iso&tlng=es

https://doi.org/10.52379/mcs.v7i1.272

Palacio Mejía LS, Wheatley Fernández JL, Ordoñez Hernández I, López Ridaura R, Lopez-Gatell Ramirez H, Hernandez Avila M, et al. Estimación del exceso de mortalidad por todas las causas durante la pandemia del Covid-19 en México. Salud Publica Mex [Internet]. 26 de febrero de 2021 [citado 25 de marzo de 2024];63(2, Mar-Abr):211-24. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34098600/

https://doi.org/10.21149/12225

PMid:34098600

Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob [Internet]. 15 de mayo de 2020 [citado 13 de marzo de 2024];19(1):1-7. Disponible en: https://ann-clinmicrob.biomedcentral.com/articles/10.1186/s12941-020-00362-2

https://doi.org/10.1186/s12941-020-00362-2

PMid:32414383 PMCid:PMC7227180

Published

2024-12-10

How to Cite

Maceda Maidana, A. R. (2024). THE C-REACTIVE PROTEIN ACCORDING TO LUNG INVOLVEMENT OF COVID-19 PATIENTS AT VERY HIGH ALTITUDE : Proteína C reactiva en COVID-19 en alta altitud. Revista De Investigación E Información En Salud, 19(47), 10. https://doi.org/10.52428/20756208.v9i21.1111

Issue

Section

Artículos Originales